基于社区和公共卫生部门的注射器服务计划之间的降低危害和过量反应服务的比较,使用全国横截面调查
Bradley R Ray1, Jamie L Humphrey1, Sheila V Patel1
1RTI International, Research Triangle Park, NC, United States.
Lancet regional health. Americas
|May 15, 2024
概括
政府资助的社区注射器服务计划 (SSP) 提供更多的过量预防服务. 足够的资金对于SSP有效解决社区需求和扩展服务至关重要.
科学领域:
- 公共卫生 公共卫生
- 药物使用障碍干预措施干预措施
- 医疗保健服务研究 医疗服务研究
背景情况:
- 注射器服务计划 (SSP) 对于减少使用毒品的人群中传染病和过量死亡至关重要.
- 美国的SSP面临着重大障碍,但最近的联邦资金为其实施提供了新的支持.
- 了解组织特征如何影响SSP服务提供对于优化其影响至关重要.
研究的目的:
- 调查SSP的组织特征与其提供关键过量预防策略之间的关联.
- 将不同类型的SSP的服务交付进行比较:公共卫生部门 (DPH),政府资助的社区组织 (CBOs) 和没有政府资助的CBOs.
主要方法:
- 来自全国注射器服务计划调查 (NSSSP) 的数据分析,涉及472个SSP.
- 检查了四个关键结果:注射器分布,纳洛分布,芬太尼试验条 (FTS) 的可用性和布普伦诺芬的实施.
- 在DPH,政府资助的CBO和没有政府资助的CBO之间比较结果,以社区级混因素进行调整.
主要成果:
- 与DPH运营的SSP相比,获得政府资助的社区组织 (CBOs) 在所有四个过量反应服务的提供量显著提高.
- 与没有政府资助的CBO SSP相比,政府资助的CBO SSP在四个服务中的三个服务中也显示出更高的供应.
- 没有政府资助的CBO SSP提供了四项服务中的三项,其费率明显高于DPH运营的SSP.
结论:
- 基于社区的注射器服务计划 (SSP) 在提供过量反应服务方面非常有效,特别是当资金充足时.
- 可持续和灵活的融资模式对于支持SSP创新及其满足不同当地需求的能力至关重要.
- 政策努力应集中在赋予CBO运营的SSP权力,以最大限度地提高其在过量预防方面的影响和影响.
相关概念视频
Healthcare Agencies II
697
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
697
Drug Control Governance: Regulatory Bodies and Their Impact
157
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
157
Dose-Response Relationship: Overview
3.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.1K
Specialized Care Centers and Settings-II
721
Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
721
Pharmacovigilance
826
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
826
Dose-Response Relationship: Potency and Efficacy
4.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.4K


